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PREFACE TO THE SECOND EDITION
The Food Safety Authority of Ireland (FSAI) published the first edition of this document in 2003.  Since 
the document was published it has been the subject of some discussion, particularly in relation to 
the hazard of transmission of Mycobacterium bovis to humans through consumption of cheeses made 
from unpasteurised milk taken from infected herds.  In drafting the original report, the Microbiology 
Sub-committee/Scientific Committee recognised the hazard associated with the consumption of 
cheese produced from unpasteurised milk in general, and the specific hazard of human infection with 
M. bovis if the milk originated from an M. bovis-infected herd. The report recognised that, when a herd 
is officially restricted due to the diagnosis of tuberculosis, either on the basis of a positive tuberculin 
test or for other reasons, it must be accepted that such a herd has been infected with Mycobacterium 
bovis for some time prior to the commencement of that restriction. Consequently, the hazard of 
contamination of milk produced by such a herd exists from some time prior to the commencement 
of that restriction and additionally, the hazard also exists that cheeses made from unpasteurised milk 
produced by such a herd during this period are also contaminated with M. bovis.
The original edition of this report sought to indicate that cheese that had been made from unpasteurised 
milk, collected from a herd that was “officially tuberculosis free” at the time of milking, but which is 
subsequently restricted because of detection of bovine tuberculosis, should not generally be regarded 
as suitable for human consumption.  In drafting the report, the members of the Sub-committee were 
conscious of the implications of such a recommendation for cheese producers and therefore, the 
report sought to identify certain very limited circumstances in which exceptions could be considered. 
It is apparent that this qualification has resulted in ambiguity in the report and that this may have 
contributed to an interpretation of the report as generally implying that restriction of the sale of such 
cheese was not warranted.  This was not the meaning intended by the Microbiology Sub-committee 
or Scientific Committee.
In view of this, the Scientific Committee requested the Microbiology Sub-committee to review the 
relevant sections of the document to determine if, in the light of experience, modification of the report 
was necessary to ensure that priority was given to ensuring clear and unambiguous advice to protect 
public health.
This report was prepared by the Microbiology Sub-committee and adopted by the Scientific Committee 
for presentation to the FSAI. It aims to provide the FSAI and other stakeholders with an overview of 
the science and related issues surrounding  the potential for transmission of zoonotic tuberculosis 
via food.
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1. SCOPE OF THE DOCUMENT
In drafting this document, the Microbiology Sub-committee of the Scientific Committee of the FSAI 
took, as its task, a consideration of the potential for transmission of zoonotic tuberculosis (i.e., 
tuberculosis from animals to humans) through the food chain.  The document does not seek to address 
issues relating to the control of transmission of tuberculosis in animals intended for food production, 
occupational risks of tuberculosis related to animal husbandry or slaughter, or control of tuberculosis 
transmission from person to person, except in so far as is necessary to provide background for the 
food safety issues.
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2. INTRODUCTION
2.1 Tuberculosis - Defining Characteristics
Tuberculosis is an infectious disease with distinctive clinical and pathological features.  Tuberculosis 
occurs in humans and many animal species including species of animals used for production of food 
(milk or meat) for human consumption (cattle, sheep, goats and deer).  The principal microorganism 
associated with human tuberculosis is Mycobacterium tuberculosis. Mycobacterium bovis is the causative 
agent of tuberculosis in animals used for production of food and accounts for a relatively small 
proportion of human cases of tuberculosis reported in Ireland.  Infection with these microorganisms is 
chronic and the infected human host may remain entirely asymptomatic or may have mild to moderate 
illness that does not come to medical attention for long periods.  In a proportion of human or animal 
hosts infected with these microorganisms, the infection may ultimately progress to severe systemic 
illness.  Pulmonary disease is the classical feature and ultimately the disease may progress to death 
of the host if untreated.  The classical pathological feature of the disease in humans is the caseating 
granuloma. This is an organised aggregation of macrophages surrounding an area of caseous necrosis.
Classically, tuberculosis is suspected in humans because of clinical features of chronic cough, weight loss 
and signs detected on clinical examination of the chest.  In human medicine, characteristic radiological 
features may support a clinical suspicion of tuberculosis, or radiological features may raise the possibility 
of tuberculosis in a person in whom it was not suspected prior to radiological examination. Tuberculosis 
may also be recognised in humans or animals by observation of characteristic macroscopic findings 
on post-mortem examination and by microscopic features of granulomatous inflammatory changes in 
tissues or lymph nodes on histopathological examination of specimens obtained ante-mortem or post-
mortem. Mycobacteria may be observed on histopathological examination of appropriately stained 
tissue sections, but the specific species of Mycobacterium present cannot be definitively identified by 
this means.
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2.2 Microbiology
The genus Mycobacterium comprises more than 70 species.  Many species of mycobacteria occur in 
the environment and are rarely associated with disease in humans or animals.  A number of species of 
mycobacteria are important pathogens of animals or humans.  Human tuberculosis is chiefly associated 
with infection with the species Mycobacterium tuberculosis, although M. africanum is also important 
in some regions.  Tuberculosis in bovines and many other animal species is primarily associated 
with infection with Mycobacterium bovis.  M. tuberculosis, M. bovis and M. africanum together with 
Mycobacterium microti (associated with infection of rodents) form a very closely related phylogenetic 
group and may be referred to collectively as the M. tuberculosis complex (MTBC).  Human infection 
with members of the MTBC produces an indistinguishable clinical picture and the individual species 
cannot be distinguished from each other based on microscopic examination of stained tissues or 
other clinical specimens.  Determination of which species is responsible for infection in a particular 
case normally requires culture of the microorganism in the laboratory.  Culture of the infecting 
microorganism remains the gold standard for diagnosis of infection with the MTBC; however, the 
process may take weeks, as the microorganisms grow slowly in vitro.  In a significant proportion of 
cases of human tuberculosis, although there is sufficient clinical and radiological evidence to establish 
a diagnosis of tuberculosis, it is not possible to culture the pathogen from any clinical specimen and 
microbiological confirmation of the diagnosis is not achieved.  Identification of the particular species 
involved may now also be accomplished by molecular methods.  Sub-typing of members of a particular 
species is also possible using molecular methods and such techniques may assist in the detection of 
relationships between microorganisms isolated from different sources.
Well-standardised methods for examination of specific foods for the presence of M. bovis have not 
been developed.  While there is no reason in principle why the methods used for culture or molecular 
detection of M. bovis from clinical specimens might not be adapted for application to foods, at present 
there is not an accepted laboratory process that would permit certification of a food product as 
“M. bovis – free”, or as “free from risk of transmission of zoonotic tuberculosis”.
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2.3 Natural History of Human Infection with the M. tuberculosis Complex 
When bacteria of the MTBC gain access to tissues they proliferate locally.  Local proliferation of 
microorganisms at the site of access to the tissues is associated with an inflammatory response 
characterised by infiltration of tissue with macrophages and other cells of the immune system. 
Macrophages phagocytose the bacteria. Following phagocytosis, macrophages present MTBC antigens 
to T-lymphocytes, which stimulate the development of an adaptive T-lymphocyte immune response 
over the subsequent weeks.
In the early stages of infection, before the adaptive immune response is fully developed, the macrophages 
are not capable of preventing proliferation of the microorganisms within the macrophage. During the 
period when the adaptive immune response is developing, the macrophages containing proliferating 
MTBC microorganisms migrate to the lymph nodes that drain the site of initial infection. From there 
they are carried to the regional lymph nodes.  For example, initial infection of the tonsils will result 
in drainage of MTBC microorganisms to the cervical lymph nodes in the first instance, while initial 
infection of the lung results in drainage of microorganisms within infected macrophages to the lymph 
nodes at the hilum of the lung.  From the regional lymph nodes the microorganisms may gain access to 
the blood and can disseminate widely throughout the body.
As the adaptive immune response develops, the stimulated T-lymphocytes interact with the macrophages 
to enhance the ability of macrophages to inactivate the microorganisms. As the cellular adaptive 
immune response develops, the cells involved form the characteristic histopathological feature, the 
granuloma.
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Arising from the complex interaction between the MTBC bacteria and the developing immunological 
response, there are a number of possible clinico-pathological outcomes for the host:
•	 in	a	small	proportion	of	infected	people	(usually	the	very	young	infant	or	those	with	profound	
impairment of the cellular immune system), there is no effective immune response and the 
microorganisms continue to proliferate throughout the body, resulting in relatively rapid 
deterioration and death.  This rapidly progressive disseminated infection is called “miliary 
tuberculosis”
•	 in	a	small	proportion	of	people,	a	localised,	self-limiting	disease	develops	within	weeks	of	initial	
infection. The classical example of a self-limiting primary infection is tuberculous inflammation 
of the pleura (pleurisy).  The progression of the infection is arrested by the development 
within about six weeks of infection of a specific cellular immune response.  This activates the 
macrophages to prevent further proliferation of the mycobacteria and resolution of the clinical 
illness follows
•	 in	the	majority	of	those	infected	with	bacteria	of	the	MTBC,	the	specific	immune	response,	
once developed, effectively controls proliferation of the bacteria before any features of clinical 
illness develop.  This is asymptomatic primary infection.  In those in whom primary infection is 
asymptomatic, the microorganism may not be completely eradicated but may remain viable in 
the tissues for many years. This is referred to as “latent” infection
•	 in	a	minority	(perhaps	5	to	10%)	of	infected	people	in	whom	the	cellular	immune	response	
initially succeeds in containing the infection, the immunological defences fail after a period of 
months or years.  The bacteria then recommence proliferation.  In general, immunological failure 
is not total. The resulting process is one of chronic tissue destruction, wasting and declining 
health over months or years.  This chronic progressive form of tuberculosis is referred to as 
“secondary tuberculosis”. The lung (pulmonary tuberculosis) is the organ most commonly 
affected (approximately 2/3 of such cases).  Clinical features include persistent cough, weight 
loss, fever, and night sweats.  Ultimately, secondary tuberculosis progresses to death in most 
cases in the absence of effective anti-tuberculosis chemotherapy.
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In	summary,	most	people	(possibly	90%)	infected	with	MTBC	microorganisms	never	develop	any	clinical	
illness related to the infection.  A small proportion of those infected develop a rapidly progressive 
disease (miliary tuberculosis) within weeks or months of infection and a further proportion develop 
chronic progressive disease months or years after an initial infection.  Those in whom the chronic 
progressive form of tuberculous pneumonia develops are the principal source of infection for humans 
as they may shed large numbers of microorganisms into the environment in infectious aerosols.
2.4 Epidemiology of Human Tuberculosis in Ireland
Human tuberculosis had been steadily declining in Ireland over the last 20 years but in recent years the 
decline in notifications has stopped (see Figure 1). 
Figure 1. Notification of Tuberculosis, Ireland 1991-2004
From a trough in 2001 of 381 cases (representing an incidence rate of 9.7 cases per 100,000 population) 
there has since been a slight increase with 408 cases reported  (or 10.4/100,000) in 2002, 407 
(or 10.4/100,000) in 2003 and 432 (or 11/100,000) in 2004 (HPSC, 2006).
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M. bovis	is	not	a	common	cause	of	tuberculosis	in	humans	in	Ireland.		Between	2000	and	2004,	55%	
to	65%	of	all	cases	of	tuberculosis	were	confirmed	by	culture	of	the	infecting	microorganism	in	the	
laboratory.		On	average,	between	1	and	4%	of	these	cultured	isolates	of	the	MTBC	are	identified	as	
being M. bovis (see Table 1) (HPSC, 2006).
Table 1.  Cases of Human Tuberculosis Confirmed on Culture as Due to M. bovis, 
2000-2004
Year Cases
Percentage of culture  
positive isolates of MTBC 
2000 2 0.9
2001 7 3.3
2002 5 2.9
2003 5 2.0
2004 5 1.8
HPSC (2006)
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3. ZOONOTIC TUBERCULOSIS
3.1 Natural History of Tuberculosis in Animals
The natural history of zoonotic tuberculosis has been best studied in cattle, although the progression 
and outcome of infections are probably similar in most species of animal used for food production in this 
country.  As with human infection, access of Mycobacterium bovis to the tissues is followed by an initial 
macrophage response that is not, however, sufficient to prevent proliferation of the microorganism. 
Dissemination of the mycobacterium to local and regional lymph nodes may be followed in rare cases 
by bloodborne spread to other organs.
In animals with clinical manifestations of tuberculosis, the respiratory tract and draining lymph nodes 
are the principal foci of disease.  Clinical manifestations and pathological lesions may also be observed 
in other organs (liver, spleen, kidney, mammary gland and bone marrow) and their associated lymph 
nodes, particularly in advanced disease.
The route of infection in most animals is via the respiratory tract.  Less commonly, M. bovis may also 
gain entry via the pharynx or gastrointestinal tract.  The principal source of infection is shedding of 
M. bovis by infected animals.  M. bovis is excreted intermittently throughout all stages of the disease and 
in particular during its advanced stages, when pulmonary lesions discharge M. bovis into the bronchi 
and the upper respiratory tract in considerable numbers. Exhalation of the bacillus follows. Likewise, 
after infective sputum is swallowed, M. bovis is excreted in the faeces and, with some reduction 
in numbers, persists in the excreta and in the contaminated slurry and environment for 330 days 
and longer.
In animals, as in humans, pre-clinical infection may be recognised by use of the tuberculin test.  This test 
is based on detection of the specific immunological response to MTBC infection.  The test involves 
intradermal injection of protein antigens derived from M. bovis (purified protein derivative, PPD) and 
inspection three days later for evidence of a local inflammatory reaction at the site of injection. In 
cattle, PPD is administered in parallel with administration at an adjacent site of protein derived from 
another species of mycobacterium that is commonly present in the environment (viz. Mycobacterium 
avium).  In cattle, interpretation of the tuberculin test is based on measurement of any alteration in 
skin fold thickness at the site of administration of M. bovis PPD and at the site of administration of the 
comparator antigen, three days after administration of PPDs.  Comparison of any increase in the skin 
fold thickness at the M. bovis PPD site with that at the site of administration of the M. avium antigen, 
relative to the initial measurements, is the basis of interpretation.  A positive reaction is indicative 
of infection with M. bovis. Animals with a positive tuberculin test are referred to as “reactors”.  All 
herds are required to have an annual test for tuberculosis carried out on all the animals within the 
herd – each year approximately ten million animal tests are carried out.  This level of testing ensures 
that there is little opportunity for the development of advanced cases of tuberculosis in cattle, thus 
minimising this possible source of infection for humans.  The tuberculin test has some limitations. 
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Very recent infection (during the weeks immediately preceding the test) may not have resulted in 
the development of the specific immune response to a detectable level at the time of testing (false 
negatives).  In practice, each year a number of cattle presented for slaughter that were negative at their 
most recent previous tuberculin test, show evidence of tuberculosis on post-mortem inspection. In 
1997, 1,700 non-tuberculin reactor cattle were found to have tuberculosis at post-mortem inspection; 
this number had increased to 2,264 in the year 2005.  This represents a very small percentage (less than 
0.002%)	of	cattle	slaughtered	each	year.
Conversely, not all reactor animals have tuberculous lesions detected on routine post-mortem 
examination.  A proportion of these animals may represent false positive tuberculin tests; however, it is 
acknowledged that the routine post-mortem examination is not a perfect instrument and that discrete 
tuberculous	lesions	may	go	undetected	in	up	to	60%	of	reactors.		It	is	also	recognised	that	M. bovis may 
be isolated on culture from lymph nodes that appear normal on gross pathological inspection.
The tuberculin test is valuable in the control of zoonotic tuberculosis because early recognition of pre-
clinical infection in animals intended for food production and early removal of infected animals from 
the herd eliminates a future source of infection for other animals and for humans.
3.2 Epidemiology of Zoonotic Tuberculosis in Ireland
Tuberculosis remains a major animal health problem in Ireland.  Most control efforts are focused on 
cattle and it is for this species that the best epidemiological information is available.  Data on the 
stocking density of standard bovine reactor animals and of animals with visible lesions per km2 indicate 
that the occurrence of tuberculosis in cattle in Ireland is highly localised. In 2005, a particular focus was 
evident both in the western central and south western counties (Figure 2).
In each year since 1997, approximately 10,000 herds have been restricted due to the diagnosis of 
tuberculosis in cattle.  Tuberculosis in herds may be identified (i) by detection of reactor animals at the 
annual tuberculin test, conducted on every herd in the State, (ii) at tests on herds currently considered 
to be at particular risk, or (iii) as a result of meat plant surveillance.  In 2006, some 24,200 cattle were 
removed as tuberculin reactors. 
Although there is much less complete information available for other animal species, infection with 
M. bovis does occur in other domestic and wild animals including goats, sheep, badgers and deer.
Consideration of the routes of transmission of zoonotic tuberculosis to cattle, of policies relating to 
the control of bovine tuberculosis and of reasons for the difficulties in controlling tuberculosis in cattle 
in Ireland, is outside the scope of this document.
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Figure 2.  Density of Tuberculosis Incidence in Cattle per Square Kilometre During 2005 
(Kernel Density with Search Radius at 10 km)
Source: CVERA, UCD
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4. LEGISLATION AND CONTROLS  
GOVERNING USE OF PRODUCTS DERIVED FROM 
TUBERCULIN REACTOR ANIMALS AS FOOD
4.1 Zoonotic Tuberculosis: Milk and Dairy Products
There is general agreement that the most critical and most effective control measure to prevent 
transmission of zoonotic tuberculosis through milk is pasteurisation or other effective heat treatment 
of milk prior to human consumption or further processing. Currently, a small number of Irish herds 
supply milk to cheesemakers who produce cheese from unpasteurised milk. 
Regulation (EC) No 853/2004 of the European Parliament and of the Council of 29 April 2004 laying 
down specific hygiene rules for food of animal origin1 prohibits milk of reactor animals from entering 
the food chain from the time tuberculosis has been diagnosed. However, milk from non-reactor animals 
in the same herd can be used for consumption or the manufacture of dairy products on condition that 
this milk is first heat treated. Therefore, this legislation prohibits the use of milk in the unpasteurised 
state from an officially positive bovine tuberculosis herd for the manufacture of milk or dairy products 
such as cheese. As an additional risk communication device, Regulation (EC) No 853/2004 also requires 
that unpasteurised dairy products, like cheeses, are labelled ‘made with raw milk’ so that the consumer 
can see that the milk used to make the product has not been heat treated.
Programmes for the early detection and elimination of M. bovis-infected cattle represent a safeguard 
against milkborne transmission of M. bovis, by ensuring that infected animals are removed from milk-
producing herds once they are diagnosed. Goat herds kept for milk production, which are kept on 
holdings which also contain cattle, are legally required to be inspected and tested for bovine tuberculosis. 
In addition, consequential testing of goats is normally performed if the goats are in contact with a cattle 
herd known to be infected with M. bovis. In other cases where goats, sheep or other species are kept 
for milk production on holdings on which cattle are not kept, Regulation 853/2004 requires that raw 
milk must come from a herd or flock that is regularly checked for tuberculosis under a control plan 
that the competent authority has approved.
1 Enacted in Irish law by S.I. No. 910 of 2005 as amended.
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4.2 Zoonotic Tuberculosis: Meat
All animals entering the food chain are subjected to ante-mortem and post-mortem inspection.  In the 
case of cattle, a tuberculin test must have been performed in the course of the 12 months prior to 
presentation for slaughter.  In the absence of such a recent tuberculin test, the cattle are rejected for 
slaughter and returned to the farm of origin.  As reactor cattle are considered likely to be infected, 
they are slaughtered separately at the end of each day to facilitate a more detailed inspection of the 
carcass for evidence of tuberculosis.
If an animal is clinically healthy at ante-mortem inspection and has no visible tuberculous lesions on 
post-mortem examination, the carcass is passed as fit for human consumption irrespective of whether 
or not it is a tuberculin reactor.  There are no barriers to trade in this meat within Ireland or within 
the European Union.  In the event that tuberculous lesions are detected in a lymph node draining one 
organ or part of the carcass only (for example, a fore quarter), that part of the carcass is declared 
unfit for human consumption. In the event that tuberculous lesions are detected on post-mortem 
examination in two or more organs or regions, the entire carcass is considered unfit for human 
consumption and is sent for destruction.
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5. POTENTIAL FOR HUMAN  
ACQUISITION OF TUBERCULOUS INFECTION  
FROM ANIMALS THROUGH THE FOOD CHAIN
5.1  Potential for the Transmission of Zoonotic Tuberculosis via Milk and Dairy Products
As outlined earlier, infection of the mammary gland may occur and may occasionally result in tuberculous 
mastitis leading to contamination of milk within the mammary gland.  Shedding of M. bovis in oral/
respiratory secretions and in faeces may occur earlier in the course of infection and before a clinical 
diagnosis of tuberculosis is suspected.  Expressed milk may become contaminated with M. bovis from 
faeces or secretions. In the past, the principal route of human infection with M. bovis in the general 
population was via ingestion of raw cow’s milk contaminated with M. bovis, rather than by inhalation 
(see Appendix 1). Human infection with M. bovis by the alimentary route is now very uncommon in 
Ireland. 
Properly controlled heat treatment of milk, e.g. pasteurisation, inactivates M. bovis and this treatment 
has had a major impact on reducing the importance of milk as a vehicle of transmission of M. bovis. 
Programmes for screening of cattle (and goats in contact with cattle) for M. bovis infection by 
tuberculin testing, as well as regular checks on registered sheep flocks and other goat herds kept for 
milk production for tuberculosis under a control plan approved by the competent authority, provide 
additional safeguards as they facilitate early detection and removal of infected animals. As mentioned 
earlier, under existing policies, reactor animals are removed and slaughtered, thereby reducing any 
likelihood of contamination of milk at source. 
There are two principal concerns with respect to the potential transfer of M. bovis via milk. These are 
the consumption of contaminated, unpasteurised milk and consumption of dairy products made from 
contaminated, unpasteurised milk.
1. Consumption of unpasteurised milk on the farm represents a hazard in relation to M. bovis2. 
Pasteurisation of milk is a well-established and readily controlled intervention to prevent 
transmission of this and other infections by milk and dairy products. Where people wish to 
consume milk produced on their own farm, the use of small-scale domestic pasteurisation units 
can reduce the risk of milkborne infection with M. bovis.  It is important that such pasteurisation 
units be properly operated and maintained.  
2. Consumption of dairy products made from unpasteurised milk represents a hazard in relation 
to M. bovis to a potentially wider population. The most common dairy product made from 
unpasteurised milk is cheese. However, the effect of the cheese production process on the 
viability of M. bovis is not well defined. Validated laboratory methods for the detection of viable 
M. bovis in milk or dairy products are not routinely available. Therefore, there is no practical way 
to assure that cheese made from unpasteurised milk can be considered “free of M. bovis”. 
2 Consumption of unpasteurised milk on the farm represents a hazard not only in relation to M. bovis,  but also in relation to 
other pathogenic bacteria, e.g., Campylobacter spp. and verotoxigenic E. coli.       
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In the event that M. bovis infection is detected in a herd, it is not possible to determine precisely at what 
point in time infection was introduced into the herd.  The infection may have occurred at any time since 
the previous tuberculin test. Indeed, the infection may have occurred during the weeks immediately 
prior to the most recent negative tuberculin test.  As outlined previously, a period of weeks may have 
elapsed between the time of infection and the time to development of positive reactor status.
When a tuberculin test, conducted on a herd that had, until recently, been classified as an “officially 
tuberculosis free herd”3 discloses a new positive tuberculin test result on an animal or animals, the 
herd is then “restricted”4. It is clear that such a restricted herd is not a suitable source of milk for the 
production of cheese from unpasteurised milk. 
In cases in which a herd previously used as a source of milk for the production of cheese without 
prior pasteurisation of the milk is newly “restricted”, there may be an amount of cheese in storage 
that was made from milk collected at a time when the herd was “officially tuberculosis free”.  Similar 
situations arise when tuberculosis is diagnosed in a goat herd or sheep flock whose milk is used in the 
raw state for the production of cheese. Decisions as to the management of such cheese have been 
controversial.  
Arguments in favour of “withdrawal from trade” of such cheese include the following:
1. it is not possible to estimate precisely at what point in time milk from the herd or flock in 
question became at risk of contamination with M. bovis
2. in the absence of pasteurisation, there are not sufficient data available to be confident that the 
cheesemaking process affords sufficient protection to the consumer
3. there is no readily available laboratory methodology to certify the product as “free of viable  
M. bovis”.
3 Officially Tuberculosis free bovine herd is defined in Article 2 (d) of Council Directive 64/432/EEC on animal health problems 
affecting intra-Community trade in bovine animals and swine, as amended. This definition requires herds to comply with Annex A 
I Paragraphs 1 and 2 of that Directive, as regards testing and freedom from TB of all animals in that herd.  
4 Restricted holding is defined in Article 2 of the Bovine Tuberculosis (Attestation of the State and General Provisions) Order, 
1989 (S.I. No. 308 of 1989) as amended. This definition refers to Article 12 of that Order regarding holdings in which bovine 
tuberculosis is present, with consequent restrictions on movement of bovine animals or their products from that holding.    
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On the other hand, it is acknowledged that:
1. if any M. bovis are present in cheese made from unpasteurised milk, the concentration is likely to 
be low provided the herd has been subjected to frequent tuberculin testing and that no animals 
in the herd show any clinical or post-mortem evidence of tuberculosis
2.  available evidence supports the view that zoonotic tuberculosis is now uncommon in Ireland.
5.2 Potential for the Transmission of Zoonotic Tuberculosis via Meat5
The distribution of tuberculous  lesions  in  cattle at slaughter, and in the other food animals such as 
pigs, sheep goats and deer, is in general, confined to the lymphatic nodes associated with the head, 
thorax and, less commonly, abdomen. One or several organs, such as the lungs, liver, spleen, kidneys 
and mammary gland along with the associated lymph nodes and related serous surfaces (pleura and 
peritoneum) are other less common sites of infection (Corner, 1994, 2006). Involvement of the muscle 
mass is rare and is mostly encountered only in the advanced stages of the disease at a time when other 
tissues show overt signs of tuberculosis (Drieux, 1957). 
 
Specific tissues (namely, lymph node, liver, spleen, kidney and mammary gland) which do not display 
visible lesions of tuberculosis at post-mortem inspection may nevertheless carry M. bovis.  Drieux 
(1957) reviewed studies of the isolation of M. bovis from skeletal muscle in cattle with advanced 
tuberculosis. Most, but not all of the investigators cited by Drieux failed to isolate M. bovis from muscle 
or were able to isolate it by guinea pig inoculation only, or infrequently by culture. This suggests that 
M. bovis was present only in low numbers. However, in two of the reports cited by Drieux, M. bovis 
was recovered from muscle in a high proportion of cases studied.  
The Advisory Committee on the Microbiological Safety of Food, in its report on Mycobacterium bovis 
to the Food Safety Agency (UK), following a qualitative risk assessment, considered that “the risk, if any, 
from the consumption of meat sold as fresh meat for human consumption following assessment and 
action by the MHS staff in UK abattoirs is very low” (Food Standards Agency, 2003).
5 The legal definition of meat in Point 1.1, Annex 1, Regulation (EC) 853/2004, refers to all edible parts of the animal including 
blood. The more common meaning of the word meat is with reference to parts of the animal harvested for human consumption, 
primarily comprised of skeletal muscle, but often containing smaller quantities of other tissue types, such as connective, neural, 
lymphatic, or vascular tissue.  This latter context is used for the purposes of this report.
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On the basis of available evidence, it is reasonable to conclude that the occurrence of viable M. bovis 
in the muscle mass of cattle, and of other food-producing animals infected with M. bovis, is uncommon. 
Recovery of M. bovis from organs such as the lungs, liver, spleen, kidneys and mammary gland is more 
common; in these cases, however, other evidence of infection is likely to be present in the form of 
visible tuberculous granulomata in the lymph nodes draining these organs. 
The scientific information available does not permit a quantitative risk assessment regarding M. bovis 
in meat. In these circumstances, the Microbiology Sub-committee considers, that given historical 
experience, and taking into account the nature and distribution of tuberculous lesions and of M. bovis 
in infected cattle (Cassidy et al., 1998), deer (Griffin and Buchan, 1994), and other food animals, the 
existing safeguards (described earlier in this report and which are subject to periodic review) are 
adequate to protect public health. However, this matter continues to be the subject of review.
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6. CONCLUSIONS
1. Current information shows that human zoonotic tuberculosis is uncommon in Ireland.
2. Transmission of zoonotic tuberculosis through milk derived from infected herds has, in the 
past, been a major public health problem that was largely solved by the introduction of milk 
pasteurisation and the programme for the eradication of tuberculosis in cattle. Therefore, there 
are grounds for concern regarding the continuing consumption of unpasteurised milk and dairy 
products derived from unpasteurised milk.  
3. Transmission of M. bovis to humans through the consumption of meat has not been  
documented as a public health concern during surveillance for tuberculosis in many countries 
over a number of decades. The risk, if any, from the consumption of meat sold as meat for 
human consumption following official controls conducted by the competent authority in 
abattoirs in Ireland is very low.
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7.1 Action to Control Zoonotic Tuberculosis
1. Efforts should continue to control or eliminate tuberculosis in cattle and other animals  
used for food production as this may be expected to reduce or eliminate the ultimate source  
of M. bovis infection.
7.2 Prevention of Transmission of Zoonotic Tuberculosis to Humans
1. The critical role of effective, well-controlled pasteurisation in ensuring the safety of milk and 
dairy products must be continually emphasised and the effectiveness of the pasteurisation 
process in individual plants should be closely monitored.
2. Milk intended to be consumed, or to be further processed, without prior heat treatment, i.e. 
pasteurisation or equivalent heat treatment, should come from registered herds or flocks that 
are subject to an official tuberculosis control plan.  In the case of cattle, the control plan should 
include herd inspection and herd testing for tuberculosis every six months to minimise the 
risk of delay in detecting infected animals. Likewise, goat herds and sheep flocks kept for milk 
production should be subject to an official tuberculosis control plan that addresses public health 
concerns in terms of food safety.
3. Cheese manufacturers producing cheese from unpasteurised milk should be required to source 
milk only from registered herds or flocks that are subject to an official tuberculosis control plan. 
4. Upon detection of tuberculosis in a herd or flock, all cheese made from unpasteurised milk 
originating from that herd or flock since the most recent herd or flock inspection or negative 
herd tuberculin test should be regarded as unsuitable for human consumption.
5. The practice of informing farmers and farm families of the particular risks associated with the 
consumption of milk from tuberculosis-positive herds should continue.
6. When private domestic consumption of milk, produced on the farm is practised by  
farm families, the use of effective and well-maintained, small-scale pasteurisation units  
is recommended.
7. Dairy farmers, cheesemakers, their families and visitors to their premises should be advised 
about the risks associated with the consumption of unpasteurised milk from any animal species.
8. At risk population groups should be alerted to the risks associated with drinking unpasteurised 
milk and consuming dairy products made from unpasteurised milk.
7. RECOMMENDATIONS
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9. The sale of unpasteurised milk intended for human consumption, originating from all farm 
animals, should be prohibited.
10. The current policy with respect to the controls on the use of beef from tuberculin reactor 
cattle should continue.
 
11. Auditing of the ante-and post-mortem inspection of carcasses at abattoirs so as to verify 
compliance with EU legislation regarding the control and removal, from the food chain,  
of carcasses or parts thereof, considered unfit for human consumption because of the  
presence of tuberculosis, or for other reasons, is recommended. 
7.3 Research and Information Gathering
1.	 Nationally,	55-65%	of	human	cases	of	tuberculosis	are	confirmed	by	culture.	M. tuberculosis 
complex bacilli isolated from humans are identified to species level to differentiate M. bovis from 
M. tuberculosis. This degree of identification is very valuable.  It would be of additional benefit 
if all isolates of M. bovis cultured from humans were subjected to detailed molecular typing to 
determine what, if any, relationships exist between strains of M. bovis currently circulating in 
cattle and other animal species (goats, badgers and deer) and those strains infecting humans.
2. Detailed investigation of all laboratory confirmed cases of human infection with M. bovis, for 
evidence of a history of consumption of unpasteurised milk or dairy products made from 
unpasteurised milk, and residence on farms at any point in their lives, is important and should 
continue to be performed. Continued, timely availability of this information at a national level  
(as provided by recent Health Protection Surveillance Centre reports) is recommended so as to 
ensure a better understanding of the epidemiology of human infection with M. bovis in Ireland.
3. Development of validated laboratory methods for routine examination of various food matrices, 
e.g. milk, dairy products and meat, for M. bovis is recommended.
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APPENDIX I
This Appendix has been added to this report in 2014 following a query raised by a member of the 
public. The query related to whether there was evidence to support the following statement that 
appears on page 16 under section 5.1:  
“In the past, the principal route of human infection with M. bovis in the general 
population was via ingestion of raw cow’s milk contaminated with M. bovis rather 
than by inhalation”. 
A review of the literature was carried out and advice was sought of the current Scientific Committee. 
The Committee was of the view that the literature generally supports the understanding that ingestion 
was a significant route of exposure for humans to M. bovis. The Committee members were also in 
agreement that the statement in the report is the generally held view. A decision was made to retain 
the statement and amend the report with this Appendix for clarification in light of the query.  
A selection of direct quotes from the literature supporting this view is listed below: 
•	 Grange	&	Yates,	1994:	
 “Milk has long been regarded as the principal mode of transmission of tubercle bacilli from cattle 
to man. There is little doubt that milk-borne infection is the principal cause of scrofula, abdominal 
tuberculosis and other non-pulmonary manifestations of the disease”
•	 Cosivi	et al., 1998: 
 “In regions where bovine TB is common and uncontrolled, milkborne infection is the principal cause of 
cervical lymphadenopathy (scrofula) and abdominal and other forms of non-pulmonary TB.”
 “Consumption of milk contaminated by M. bovis has long been regarded as the principal mode of TB 
transmission from animals to humans (Acha, P.N. & Szyfres, 1987)” 
•	 Ashford	et al., 2001: 
 “Milk is still regarded as the principal vehicle for transmission to humans in countries where bovine 
tuberculosis is not controlled”
•	 Smith	et al., 2004: 
 “In the past, Mycobacterium bovis was a major source of tuberculosis in humans through 
consumption of unpasteurised milk” 
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•	 de	la	Rua-Domenech,	2006:	
 “In industrialized countries such as the UK and Ireland, where milk pasteurization is widespread 
or compulsory, bovine TB no longer poses a risk to the urban population despite a relatively high 
incidence of TB in the national cattle herds.” 
 “Historically, in Western Europe and in the UK in particular, unpasteurised milk derived from infected 
cows was regarded as the principal vehicle of infection for humans before the advent of compulsory 
milk pasteurisation (Anon 1965; Pritchard, 1988; Danker et al, 1993).” 
•	 Theon	et al., 2006:
 “Historically, M. bovis has been associated with extrapulmonary tuberculosis in infants and children, 
usually occurring due to the consumption of milk, which had not been pasteurized or boiled, from 
infected cattle”
•	 Wilkins	et al., 2008: 
 “Historically, M. bovis infection in humans was associated with consumption of unpasteurised milk 
and dairy products (Wigle et al., 1972; Enarson, et al., 2006).”
•	 Mandal	et al., 2011: 
 “The main mode of transmission of M. bovis to humans is believed to be from cattle via consumption 
of unpasteurized dairy products (Grange, 2001). Less frequently, aerosol inhalation following close 
contact with infectious cattle, e.g., on farms or in abattoirs (Grange, 2001), and from other animals, 
including household pets, has been described (Shrikrishna, et al., 2009).”
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